Trial Profile
A Randomised, open-label study to compare the effect of Liraglutide plus Insulin with Insulin alone in the reduction of Visceral Fat in patients with Type II Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Jul 2017
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary) ; Insulin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 17 Jul 2017 New trial record
- 13 Jun 2017 Results presented at the 77th Annual Scientific Sessions of the American Diabetes Association